A defined microbiome therapeutic prevents recurrent Clostridioides difficile

被引：0
|
作者：
Khanna, Sahil [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 6卷 / 04期
关键词：
INFECTION; UPDATE;
D O I：
10.1016/S2468-1253(21)00011-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [1] Microbiome therapy for recurrent Clostridioides difficile
    Gilbert, Judith A.
    LANCET MICROBE, 2022, 3 (05): : E334 - E334
  • [2] Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection
    Bloom, Patricia P.
    Young, Vincent B.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 89 - 101
  • [3] Recurrent Clostridioides difficile infection: treat the microbiome as well!
    Klein, Friederike
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (05): : 729 - 729
  • [4] Oral microbiome therapy for recurrent Clostridioides difficile infection
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (03): : 205 - 205
  • [5] Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection
    Hamilton, Fergus
    Wright, William F.
    Lee, Todd C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12):
  • [6] Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With Recurrent Clostridioides difficile Infection
    Straub, Timothy J.
    Lombardo, Mary-Jane
    Bryant, Jessica A.
    Diao, Liyang
    Lodise, Thomas P.
    Freedberg, Daniel E.
    Wortman, Jennifer R.
    Litcofsky, Kevin D.
    Hasson, Brooke R.
    Mcgovern, Barbara H.
    Ford, Christopher B.
    Henn, Matthew R.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (04) : 833 - 841
  • [7] SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)
    Khanna, Sahil
    Sims, Matthew
    Louie, Thomas J.
    Fischer, Monika
    LaPlante, Kerry
    Allegretti, Jessica
    Hasson, Brooke R.
    Fonte, Allyson T.
    McChalicher, Christopher
    Ege, David S.
    Bryant, Jessica A.
    Straub, Timothy J.
    Ford, Christopher B.
    Henn, Matthew R.
    Wang, Elaine E. L.
    von Moltke, Lisa
    Wilcox, Mark H.
    ANTIBIOTICS-BASEL, 2022, 11 (09):
  • [8] Prescription Microbiome Therapeutic for Recurrent Clostridioides difficile Infection: Fecal Microbiota Live-js']jslm
    Oneto, Caterina
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (1S): : S16 - S21
  • [9] Oral microbiome therapeutic for recurrent C difficile
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (12): : 1087 - 1087
  • [10] The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection
    Seekatz, Anna Maria
    Safdar, Nasia
    Khanna, Sahil
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
12345